OPTIMIZING TREATMENT EFFICACY: RTMS VS. ITBS IN MAJOR DEPRESSIVE DISORDER MANAGEMENT IN TAIWAN

被引：0
|
作者：
Tien, Yun [1 ]
Huang, Shang-Chien [2 ]
Huang, Hsiang-Ping [3 ]
机构：
[1] Taoyuan Psychiat Ctr, Dept Psychiat, Taoyuan, Taiwan
[2] Tungs Taichung MetroHarbor Hosp, Dept Psychiat, Taichung, Taiwan
[3] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2025年 / 28卷
关键词：
major depressive disorder; rTMS; iTBS;
D O I：
10.1093/ijnp/pyae059.339
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
pyae059.33
引用
收藏
页码：i195 / i196
页数：2
相关论文
共 50 条
  • [31] Speed of antidepressant response to electroconvulsive therapy in bipolar disorder vs. major depressive disorder
    Agarkar, Smita
    Hurt, Stephen W.
    Young, Robert C.
    PSYCHIATRY RESEARCH, 2018, 265 : 355 - 359
  • [32] The dissociation of trait dependent VPFC activation in bipolar disorder vs. major depressive disorder
    Chepenik, LG
    Kalmar, JH
    Wang, F
    Jones, MM
    Colonese, K
    Weder, ND
    Blumberg, HP
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 172S - 172S
  • [33] Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder
    Amital, D.
    Fostick, L.
    Silberman, A.
    Calati, R.
    Spindelegger, C.
    Serretti, A.
    Juven-Wetzler, A.
    Souery, D.
    Mendlewicz, J.
    Montgomery, S.
    Kasper, S.
    Zohar, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (08) : 895 - 901
  • [34] Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation
    Llorca, P. M.
    Fernandez, J. -L.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (04) : 702 - 710
  • [35] Escitalopram vs venlafaxine XR treatment of major depressive disorder
    Montgomery, SA
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S207 - S207
  • [36] A naturalistic analysis of rTMS treatment outcomes for major depressive disorder in West Australian youth
    Miljevic, Aleksandra
    Hoath, Kyle
    Leggett, Kerry S.
    Hennessy, Lauren A.
    Boax, Caitlan A.
    Hryniewicki, Jaroslaw
    Rodger, Jennifer
    FRONTIERS IN PSYCHIATRY, 2025, 16
  • [37] Clinical assessment of NaSSA vs. SSRI efficacy in major depressive episode
    Tudor, C
    Gheorghe, MD
    Grigorescu, G
    Marinescu, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S192 - S192
  • [38] Predictors of response to repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive disorder
    Beuzon, G.
    Timour, Q.
    Saoud, M.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2017, 43 (01): : 3 - 9
  • [39] Time-frequency analysis in EEG for the Treatment of Major Depressive Disorder Using rTMS
    Nikravan, Mehran
    Ebrahimzadeh, Elias
    PROCEEDINGS OF THE 2021 ASIA-PACIFIC INTERNATIONAL SYMPOSIUM ON ELECTROMAGNETIC COMPATIBILITY (APEMC 2021), 2021,
  • [40] rTMS Using Summation of Electromagnetic Fields from a Two-coil Array: Efficacy for Treatment Resistant Major Depressive Disorder
    Carpenter, Linda
    Aaronson, Scott
    Clarke, Gregory
    Holtzheimer, Paul
    Johnson, Clark
    McDonald, William
    Stannard, Elizabeth
    Schneider, M. Bret
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S365 - S366
12345